{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:55:48Z","timestamp":1792439748054,"version":"4.5.0"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22fk0210064"],"award-info":[{"award-number":["JP22fk0210064"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22fk0310512"],"award-info":[{"award-number":["JP22fk0310512"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Extracellular vesicles (EVs) contain proteins, mRNAs, and microRNAs, and their cargos have emerged as novel diagnostic markers in various diseases. We aimed to discover novel and noninvasive biomarkers of liver fibrosis by proteomic analysis using serum EVs in patients with chronic hepatitis C. We performed shotgun proteomics using serum EVs isolated from 54 patients with histologically assessed liver fibrosis. Shotgun proteomics identified a total of 974 proteins, and 445 proteins were detected in more than half of the patients. Among them, a total of 9 proteins were identified as proteins that tended to increase or decrease with liver fibrosis with a significance of p&lt;0.005 and that were different between F1-2 patients and F3-4 patients with a significance of p&lt;0.01. Among the 9 proteins, targeted proteomics using serum EVs isolated from the sera of another 80 patients with histologically assessed liver fibrosis verified that serum amyloid P component (SAP) and pro-platelet basic protein (PPBP) levels in EVs significantly decreased with the progression of liver fibrosis and were significantly lower in F3-4 patients than in F1-2 patients. The diagnostic accuracies of SAP and PPBP in EVs for the liver fibrosis stage were comparable to those of type IV collagen 7S, hyaluronic acid, and the fibrosis-4 index (FIB-4 index). Moreover, serum SAP and PPBP levels correlated with the levels in EVs, and the ability of serum SAP and PPBP to diagnose liver fibrosis stage was also comparable to the abilities of type IV collagen 7S, hyaluronic acid, and the FIB-4 index. In conclusion, proteomic analysis of serum EVs identified SAP and PPBP as candidate biomarkers for predicting liver fibrosis in patients with chronic hepatitis C. In addition, SAP and PPBP levels in serum are strongly correlated with those in EVs and could represent markers of liver fibrosis.<\/jats:p>","DOI":"10.1371\/journal.pone.0271020","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T13:32:09Z","timestamp":1657200729000},"page":"e0271020","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients"],"prefix":"10.1371","volume":"17","author":[{"given":"Kumiko","family":"Shirai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Hikita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadatsugu","family":"Sakane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Narumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1580-607X","authenticated-orcid":true,"given":"Ryotaro","family":"Sakamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohide","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Mita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tomonaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5036-3457","authenticated-orcid":true,"given":"Tetsuo","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"issue":"9055","key":"pone.0271020.ref001","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C","volume":"349","author":"The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","year":"1997","journal-title":"Lancet"},{"issue":"17","key":"pone.0271020.ref002","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.2018.3795","article-title":"Chronic Hepatitis B Infection: A Review","volume":"319","author":"LSY Tang","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"pone.0271020.ref003","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"HK Seitz","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"pone.0271020.ref004","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"S Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9930","key":"pone.0271020.ref005","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"EA Tsochatzis","year":"2014","journal-title":"Lancet"},{"issue":"8480","key":"pone.0271020.ref006","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(86)90883-4","article-title":"Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver","volume":"1","author":"B Maharaj","year":"1986","journal-title":"Lancet"},{"issue":"6","key":"pone.0271020.ref007","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/jhep.2003.09022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"P Bedossa","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"pone.0271020.ref008","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1389201033489810","article-title":"Invasive and non-invasive monitoring of hepatitis C virus-induced liver fibrosis: alternatives or complements?","volume":"4","author":"OZ Olga","year":"2003","journal-title":"Curr Pharm Biotechnol"},{"issue":"4","key":"pone.0271020.ref009","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/clinchem\/42.4.558","article-title":"Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis","volume":"42","author":"J Gu\u00e9chot","year":"1996","journal-title":"Clin Chem"},{"issue":"5","key":"pone.0271020.ref010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00535-021-01782-3","article-title":"Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis","volume":"56","author":"J Itakura","year":"2021","journal-title":"J Gastroenterol"},{"issue":"7","key":"pone.0271020.ref011","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"R Loomba","year":"2020","journal-title":"Gut"},{"issue":"8","key":"pone.0271020.ref012","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/biosci\/biv084","article-title":"Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study","volume":"65","author":"MP Zaborowski","year":"2015","journal-title":"Bioscience"},{"issue":"5","key":"pone.0271020.ref013","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"S EL Andaloussi","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"pone.0271020.ref014","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/cas.13862","article-title":"Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer","volume":"110","author":"L Niu","year":"2019","journal-title":"Cancer Sci"},{"issue":"9","key":"pone.0271020.ref015","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/hep4.1556","article-title":"Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH","volume":"4","author":"D Povero","year":"2020","journal-title":"Hepatol Commun"},{"issue":"1","key":"pone.0271020.ref016","doi-asserted-by":"crossref","first-page":"12782","DOI":"10.1038\/s41598-017-13092-x","article-title":"Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics","volume":"7","author":"T Shiromizu","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0271020.ref017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C","volume":"20","author":"The French METAVIR Cooperative Study Group","year":"1994","journal-title":"Hepatology"},{"issue":"6","key":"pone.0271020.ref018","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"DE Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"pone.0271020.ref019","doi-asserted-by":"crossref","first-page":"33935","DOI":"10.1038\/srep33935","article-title":"A novel affinity-based method for the isolation of highly purified extracellular vesicles","volume":"6","author":"W Nakai","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0271020.ref020","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1021\/pr700658q","article-title":"Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis","volume":"7","author":"T Masuda","year":"2008","journal-title":"J Proteome Res"},{"issue":"8","key":"pone.0271020.ref021","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nprot.2007.261","article-title":"Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips","volume":"2","author":"J Rappsilber","year":"2007","journal-title":"Nat Protoc"},{"issue":"1","key":"pone.0271020.ref022","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"dW Huang","year":"2009","journal-title":"Nat Protoc"},{"issue":"12","key":"pone.0271020.ref023","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"J Cox","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"7","key":"pone.0271020.ref024","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"B MacLean","year":"2010","journal-title":"Bioinformatics"},{"issue":"6","key":"pone.0271020.ref025","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF03401789","article-title":"Human serum amyloid P component is a single uncomplexed pentamer in whole serum","volume":"6","author":"WL Hutchinson","year":"2000","journal-title":"Mol Med"},{"issue":"12","key":"pone.0271020.ref026","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/jth.13147","article-title":"Platelet secretory behaviour: as diverse as the granules \u2026 or not?","volume":"13","author":"H Heijnen","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"4","key":"pone.0271020.ref027","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/pmic.201000422","article-title":"Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery","volume":"11","author":"F Raimondo","year":"2011","journal-title":"Proteomics"},{"key":"pone.0271020.ref028","doi-asserted-by":"crossref","first-page":"31209","DOI":"10.3402\/jev.v5.31209","article-title":"Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array","volume":"5","author":"JL Welton","year":"2016","journal-title":"J Extracell Vesicles"},{"issue":"15","key":"pone.0271020.ref029","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-018-2773-4","article-title":"Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins","volume":"75","author":"N Karimi","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"pone.0271020.ref030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","article-title":"The human plasma proteome: history, character, and diagnostic prospects","volume":"1","author":"NL Anderson","year":"2002","journal-title":"Mol Cell Proteomics"},{"issue":"8","key":"pone.0271020.ref031","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.7150\/ijbs.59725","article-title":"Could protein content of Urinary Extracellular Vesicles be useful to detect Cirrhosis in Alcoholic Liver Disease?","volume":"17","author":"E Gonzalez","year":"2021","journal-title":"Int J Biol Sci"},{"key":"pone.0271020.ref032","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biochi.2020.08.013","article-title":"Discovery of small extracellular vesicle proteins from human serum for liver cirrhosis and liver cancer","volume":"177","author":"A Uzzaman","year":"2020","journal-title":"Biochimie"},{"issue":"11\u201312","key":"pone.0271020.ref033","article-title":"Quantitative proteome analysis of plasma microparticles for the characterization of HCV-induced hepatic cirrhosis and hepatocellular carcinoma","volume":"11","author":"RSZ Taleb","year":"2017","journal-title":"Proteomics Clin Appl"},{"issue":"11","key":"pone.0271020.ref034","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.4049\/jimmunol.149.11.3689","article-title":"Serum amyloid P component binds to histones and activates the classical complement pathway","volume":"149","author":"PS Hicks","year":"1992","journal-title":"J Immunol"},{"issue":"2","key":"pone.0271020.ref035","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1006\/bbrc.1994.1760","article-title":"Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer\u2019s disease","volume":"201","author":"PN Hawkins","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"pone.0271020.ref036","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1159\/000178756","article-title":"Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer\u2019s disease","volume":"26","author":"NA Verwey","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"pone.0271020.ref037","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpsychires.2021.12.051","article-title":"Serum amyloid P component level is associated with clinical response to escitalopram treatment in patients with major depressive disorder","volume":"146","author":"J Yang","year":"2022","journal-title":"J Psychiatr Res"},{"key":"pone.0271020.ref038","doi-asserted-by":"crossref","first-page":"3081891","DOI":"10.1155\/2021\/3081891","article-title":"Parkinson\u2019s Disease-Related Biomarkers That May Appear in Amphetamine Abusers","volume":"2021","author":"A Al-Rafiah","year":"2021","journal-title":"Biomed Res Int"},{"issue":"4","key":"pone.0271020.ref039","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5935\/0004-2749.20190055","article-title":"Intravitreal neurodegenerative and inflammatory mediators in proliferative diabetic retinopathy","volume":"82","author":"F Mallmann","year":"2019","journal-title":"Arq Bras Oftalmol"},{"issue":"6","key":"pone.0271020.ref040","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4049\/immunohorizons.2000043","article-title":"Reduced Sialylation and Bioactivity of the Antifibrotic Protein Serum Amyloid P in the Sera of Patients with Idiopathic Pulmonary Fibrosis","volume":"4","author":"W Chen","year":"2020","journal-title":"Immunohorizons"},{"issue":"19","key":"pone.0271020.ref041","doi-asserted-by":"crossref","first-page":"10598","DOI":"10.1039\/C7RA12956D","article-title":"Identification of potential serum biomarkers of acute paraquat poisoning in humans using an iTRAQ quantitative proteomic","volume":"8","author":"L Wei","year":"2018","journal-title":"RSC Adv"},{"issue":"6","key":"pone.0271020.ref042","first-page":"427","article-title":"Serum amyloid P-component as a marker of liver disease","volume":"77","author":"Y Levo","year":"1982","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"pone.0271020.ref043","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/apt.13292","article-title":"Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease","volume":"42","author":"EC Verna","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"pone.0271020.ref044","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3389\/fimmu.2018.02328","article-title":"The Development of Serum Amyloid P as a Possible Therapeutic","volume":"9","author":"D Pilling","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"pone.0271020.ref045","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3892\/ijmm.2017.3028","article-title":"Protective effect of human serum amyloid P on CCl4-induced acute liver injury in mice","volume":"40","author":"M Cong","year":"2017","journal-title":"Int J Mol Med"},{"issue":"2","key":"pone.0271020.ref046","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3892\/or.2016.5312","article-title":"CXCL7 promotes proliferation and invasion of cholangiocarcinoma cells","volume":"37","author":"Q Guo","year":"2017","journal-title":"Oncol Rep"},{"issue":"1","key":"pone.0271020.ref047","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12944-017-0471-0","article-title":"PPBP and DEFA1\/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease","volume":"16","author":"Y Maneerat","year":"2017","journal-title":"Lipids Health Dis"},{"issue":"1","key":"pone.0271020.ref048","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12967-019-1962-8","article-title":"Proteomic profiling of plasma biomarkers in acute ischemic stroke due to large vessel occlusion","volume":"17","author":"C Qin","year":"2019","journal-title":"J Transl Med"},{"issue":"2","key":"pone.0271020.ref049","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cam4.1292","article-title":"CTAPIII\/CXCL7: a novel biomarker for early diagnosis of lung cancer","volume":"7","author":"Q Du","year":"2018","journal-title":"Cancer Med"},{"issue":"1","key":"pone.0271020.ref050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1158\/1055-9965.EPI-10-0397","article-title":"Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancer","volume":"20","author":"J Matsubara","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"pone.0271020.ref051","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ygyno.2011.06.002","article-title":"Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer","volume":"122","author":"CH Clarke","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"7","key":"pone.0271020.ref052","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/bjc.2017.276","article-title":"CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas","volume":"117","author":"M Dufies","year":"2017","journal-title":"Br J Cancer"},{"issue":"11","key":"pone.0271020.ref053","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/resp.13668","article-title":"Analysis by proteomics reveals unique circulatory proteins in idiopathic pulmonary fibrosis","volume":"24","author":"YP Moodley","year":"2019","journal-title":"Respirology"},{"issue":"3","key":"pone.0271020.ref054","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1189\/jlb.0603288","article-title":"Constitutive and regulated expression of platelet basic protein in human monocytes","volume":"75","author":"A El-Gedaily","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"3","key":"pone.0271020.ref055","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0091-6749(92)90372-9","article-title":"Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils","volume":"89","author":"SR Reddigari","year":"1992","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"pone.0271020.ref056","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/infdis\/jiu490","article-title":"Elevated levels of the neutrophil chemoattractant pro-platelet basic protein in macrophages from individuals with chronic and allergic aspergillosis","volume":"211","author":"NL Smith","year":"2015","journal-title":"J Infect Dis"},{"key":"pone.0271020.ref057","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-230X-11-91","article-title":"Non-invasive markers for hepatic fibrosis","volume":"11","author":"A Baranova","year":"2011","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"pone.0271020.ref058","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2893.2009.01083.x","article-title":"The HCV serum proteome: a search for fibrosis protein markers","volume":"16","author":"KJ Cheung","year":"2009","journal-title":"J Viral Hepat"},{"issue":"6","key":"pone.0271020.ref059","doi-asserted-by":"crossref","first-page":"e39603","DOI":"10.1371\/journal.pone.0039603","article-title":"Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study","volume":"7","author":"B Gangadharan","year":"2012","journal-title":"PLoS One"},{"key":"pone.0271020.ref060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1479-5876-5-33","article-title":"Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection","volume":"5","author":"IR White","year":"2007","journal-title":"J Transl Med"},{"issue":"11","key":"pone.0271020.ref061","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1007\/s10620-011-1745-4","article-title":"Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics","volume":"56","author":"L Yang","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"8","key":"pone.0271020.ref062","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep4.1721","article-title":"Cluster of Differentiation 44 Promotes Liver Fibrosis and Serves as a Biomarker in Congestive Hepatopathy","volume":"5","author":"Y Osawa","year":"2021","journal-title":"Hepatol Commun"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0271020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T22:09:56Z","timestamp":1676066996000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0271020"}},"subtitle":[],"editor":[{"given":"Jon M.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":62,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0271020","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]}}}